Status:
RECRUITING
Sensory Rehabilitation in Chemotherapy Induced Peripheral Neuropathy (CIPN)
Lead Sponsor:
Assaf-Harofeh Medical Center
Collaborating Sponsors:
Zefat Academic College
Conditions:
CIPN
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
Physiotherapist research about Sensory rehabilitation in chemotherapy induced peripheral neuropathy (CIPN) with the aid of questioners and physiotherapy practice
Eligibility Criteria
Inclusion
- Patients aged 18 and over who suffer from chemotherapy-induced neuropathy (CIPN), according to the patient's report, more than 3 months since the end of the chemotherapy treatment.
Exclusion
- Sensory damage / neuropathy that existed even before the start of chemotherapy
- Incidents of recurrent falls even before the start of chemotherapy (over 2 falls for 6 months)
- Central nervous system involvement
- Major pre-morbid orthopedic lower limb impairment
- Hebrew language not sufficient for assessment and treatment
Key Trial Info
Start Date :
August 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT05382520
Start Date
August 1 2022
End Date
December 1 2025
Last Update
January 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shamir medical center
Beer Yaaqov, Israel